Measure number |
Measure Name |
2015 reporting period |
|
ACO |
Mean performance rate (SSP- ACOs) |
|
performance rate |
|
ACO-1 |
CAHPS: Getting Timley Care, Appointments, and Information |
86.64 |
80.61 |
|
ACO-2 |
CAHPS: How Well Your Providers Communicate |
92.81 |
92.65 |
|
ACO-3 |
CAHPS: Patients' Rating of Provider |
91.9 |
91.94 |
|
ACO-4 |
CAHPS: Access to Specialists |
82.89 |
83.61 |
|
ACO-5 |
CAHPS: Health Promotion and Education |
53.16 |
59.06 |
|
ACO-6 |
CAHPS: Shared Decision Making |
72.1 |
75.17 |
|
ACO-7 |
CAHPS: Health Status/Functional Status |
71.88 |
72.30 |
|
ACO-34 |
CAHPS: Stewardship of Patient Resources* |
26.04 |
26.87 |
|
ACO-8 |
Risk Standardized, All Condition Readmission |
15.18 |
14.86 |
|
ACO-35 |
Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)* Readmission |
17.05 |
18.07 |
|
ACO-36 |
All-Cause Unplanned Admissions for Patients with Diabetes* |
71.72 |
54.60 |
|
ACO-37 |
All-Cause Unplanned Admissions for Patients with Heart Failure* |
104.26 |
76.96 |
|
ACO-38 |
All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions |
82.68 |
62.92 |
|
ACO-9 |
Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5 |
1.42 |
1.11 |
|
ACO-10 |
Ambulatory Sensitive Conditions Admission: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 |
1.38 |
1.04 |
|
ACO-11 |
Percent of Primary Care Physicians who Successfully Meet Meaningful Use Requirements |
100% |
76.22% |
|
ACO-39 |
Documentation of Current Medications in the Medical Record* |
22.81% |
84.07% |
|
ACO-13 |
Falls: Screening for Future Fall Risk |
78.31% |
56.46% |
|
ACO-14 |
Preventive Care and Screening: Influenza Immunization |
73.29% |
62.03% |
|
ACO-15 |
Pneumonia Vaccination Status for Older Adults |
82.49% |
63.73% |
|
ACO-16 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up Plan |
78.00% |
71.15% |
|
ACO-17 |
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention |
91.16% |
90.16% |
|
ACO-18 |
Preventive Care and Screening: Screening for Clinical Depression and Follow-up |
67.05% |
45.25% |
|
ACO-19 |
Colorectal Cancer Screening |
58.06% |
60.06% |
|
ACO-20 |
Breast Cancer Screening |
78.80% |
65.67% |
|
ACO-21 |
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented |
36.40% |
70.04% |
|
ACO-40 |
Depression Remission at Twelve Months* |
N/A |
N/A |
|
ACO-27 |
Diabetes Mellitus: Hemoglobin A1c Poor Control |
10.89% |
20.38% |
|
ACO-41 |
Diabetes: Eye Exam* |
40.86% |
41.05% |
|
ACO-28 |
Hypertension: Controlling High Blood Pressure |
68.13% |
69.62% |
|
ACO-30 |
Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic |
75.81% |
83.82% |
|
ACO-31 |
Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
85.79% |
87.22% |
|
ACO-33 |
Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy = for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) |
75.00% |
77.73% |
|
CAHPS= Consumer Assessment of Healthcare Providers and Systems, PQI= Prevention Quality Indicator, LVSD= left ventricular systolic dysfunction, ACE= angiotensin-converting enzyme, ARB= angiotensin receptor blocker, CAD= coronary artery disease
*= Measure required beginning Reporting Year 2015.
N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A |
|
|
|
|
|